375 related articles for article (PubMed ID: 30589490)
1. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.
Lee HA; Kim SU; Seo YS; Lee YS; Kang SH; Jung YK; Kim MY; Kim JH; Kim SG; Suk KT; Jung SW; Jang JY; An H; Yim HJ; Um SH
Liver Int; 2019 Jun; 39(6):1071-1079. PubMed ID: 30589490
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.
Galizzi HO; Couto CA; Taranto DOL; Araújo SIO; Vilela EG
Ann Hepatol; 2021; 20():100229. PubMed ID: 32745630
[TBL] [Abstract][Full Text] [Related]
3. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Saraya A
Am J Gastroenterol; 2020 Oct; 115(10):1650-1656. PubMed ID: 32516202
[TBL] [Abstract][Full Text] [Related]
4. Elastography-based screening for esophageal varices in patients with advanced chronic liver disease.
Paternostro R; Reiberger T; Bucsics T
World J Gastroenterol; 2019 Jan; 25(3):308-329. PubMed ID: 30686900
[TBL] [Abstract][Full Text] [Related]
5. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis.
Berzigotti A; Seijo S; Arena U; Abraldes JG; Vizzutti F; García-Pagán JC; Pinzani M; Bosch J
Gastroenterology; 2013 Jan; 144(1):102-111.e1. PubMed ID: 23058320
[TBL] [Abstract][Full Text] [Related]
6. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
[TBL] [Abstract][Full Text] [Related]
7. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
[TBL] [Abstract][Full Text] [Related]
8. Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Moctezuma-Velazquez C; Saffioti F; Tasayco-Huaman S; Casu S; Mason A; Roccarina D; Vargas V; Nilsson JE; Tsochatzis E; Augustin S; Montano-Loza AJ; Berzigotti A; Thorburn D; Genesca J; Abraldes JG
Am J Gastroenterol; 2019 Mar; 114(3):446-452. PubMed ID: 30315285
[TBL] [Abstract][Full Text] [Related]
9. Age, Sex, and Body Mass Index Should Be Considered When Assessing Spleen Length in Patients with Compensated Advanced Chronic Liver Disease.
Lee HA; Kim SU; Lim J; Kim MY; Kim SG; Suk KT; Jang JY; An H; Yim HJ; Seo YS
Gut Liver; 2023 Mar; 17(2):299-307. PubMed ID: 36424721
[TBL] [Abstract][Full Text] [Related]
10. Liver stiffness by two-dimensional shear wave elastography for screening high-risk varices in patients with compensated advanced chronic liver disease.
Yan Y; Xing X; Wang X; Yang L
Eur Radiol; 2022 Mar; 32(3):2078-2088. PubMed ID: 34713329
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.
Tosetti G; Primignani M; La Mura V; D'Ambrosio R; Degasperi E; Mezzina N; Viganò M; Rumi M; Fracanzani AL; Lombardi R; Fargion S; Fraquelli M; Aghemo A; Lampertico P
Dig Liver Dis; 2019 Aug; 51(8):1135-1140. PubMed ID: 30691777
[TBL] [Abstract][Full Text] [Related]
13. Assessing Baveno VI criteria with liver stiffness measured using a new point-shear wave elastography technique (BAVElastPQ study).
Garcovich M; Di Stasio E; Zocco MA; Riccardi L; Ainora ME; Annicchiarico BE; Gibiino G; Santopaolo F; Gasbarrini A; Pompili M
Liver Int; 2020 Aug; 40(8):1952-1960. PubMed ID: 32510772
[TBL] [Abstract][Full Text] [Related]
14. Course of oesophageal varices and performance of noninvasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease.
Giannini EG; De Maria C; Crespi M; Demarzo MG; Fazio V; Grasso A; Torre F; Bodini G; Marabotto E; Furnari M
Eur J Clin Invest; 2020 May; 50(5):e13231. PubMed ID: 32291753
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of noninvasive methods including assessment of liver stiffness by 2-dimensional shear wave elastography for predicting esophageal varices.
Yoo HW; Kim YS; Kim SG; Yoo JJ; Jeong SW; Jang JY; Lee SH; Kim HS; Kim YD; Cheon GJ; Jun B; Kim BS
Dig Liver Dis; 2019 Dec; 51(12):1706-1712. PubMed ID: 31281068
[TBL] [Abstract][Full Text] [Related]
16. Spleen stiffness in patients with cirrhosis in predicting esophageal varices.
Sharma P; Kirnake V; Tyagi P; Bansal N; Singla V; Kumar A; Arora A
Am J Gastroenterol; 2013 Jul; 108(7):1101-7. PubMed ID: 23629600
[TBL] [Abstract][Full Text] [Related]
17. Baveno Criteria Safely Identify Patients With Compensated Advanced Chronic Liver Disease Who Can Avoid Variceal Screening Endoscopy: A Diagnostic Test Accuracy Meta-Analysis.
Szakács Z; Erőss B; Soós A; Mátrai P; Szabó I; Pétervári E; Bajor J; Farkas N; Hegyi P; Illés A; Solymár M; Balaskó M; Sarlós P; Szűcs Á; Czimmer J; Vincze Á; Pár G
Front Physiol; 2019; 10():1028. PubMed ID: 31481896
[No Abstract] [Full Text] [Related]
18. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
[TBL] [Abstract][Full Text] [Related]
19. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate" study.
Abraldes JG; Bureau C; Stefanescu H; Augustin S; Ney M; Blasco H; Procopet B; Bosch J; Genesca J; Berzigotti A;
Hepatology; 2016 Dec; 64(6):2173-2184. PubMed ID: 27639071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
